{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:08:24Z","timestamp":1792786104259,"version":"4.5.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"University of Central Florida FIRE Program","id":[{"id":"https:\/\/ror.org\/036nfer12","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pneumococcal conjugate vaccines (PCV) reduce invasive disease and routine pediatric infections, yet subtherapeutic antibody responses have been reported in children with refractory otolaryngologic disease. This study evaluated pneumococcal antibody responses in a community cohort of vaccinated children and compared findings with prior specialty cohorts and prelicensure trial data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Serum from children aged 15\u201336\u00a0months with a documented four-dose PCV series was analysed for IgG concentrations to 14 serotypes. Protective thresholds were defined for invasive disease (\u22650.35\u00a0\u03bcg\/ml) and noninvasive disease (\u22651.3 and\u00a0\u2265\u00a02.0\u00a0\u03bcg\/ml). Results were compared with published pediatric cohorts and prelicensure trial data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 77.1% of children met the invasive disease threshold. Only 31.3% and 18.8% met the \u22651.3 and\u00a0\u2265\u00a02.0\u00a0\u03bcg\/ml thresholds, respectively. Antibody levels were consistently lower than those reported in prior cohorts and prelicensure trials across most serotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings suggest that real-world immunogenicity following routine PCV may differ from that observed in strictly defined and controlled clinical trial populations, particularly at higher antibody thresholds associated with noninvasive disease. Larger-scale, prospective studies are needed to determine if trends hold across broader cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/pubmed\/fdag081","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:06:35Z","timestamp":1792771595000},"source":"Crossref","is-referenced-by-count":0,"title":["Cross-sectional analysis of pneumococcal conjugate vaccine immunity in infants from the community"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4331-8256","authenticated-orcid":false,"given":"Ajay","family":"Bharathan","sequence":"first","affiliation":[{"name":"University of Central Florida - , Department of Medicine, 6850 Lake Nona Blvd, Orlando, FL 32827 ,","place":["USA"]},{"name":"College of Medicine - , Department of Medicine, 6850 Lake Nona Blvd, Orlando, FL 32827 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9939-2985","authenticated-orcid":false,"given":"Adele K","family":"Evans","sequence":"additional","affiliation":[{"name":"University of Central Florida - , Department of Medicine, 6850 Lake Nona Blvd, Orlando, FL 32827 ,","place":["USA"]},{"name":"College of Medicine - , Department of Medicine, 6850 Lake Nona Blvd, Orlando, FL 32827 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"2026102312062575200_ref1","volume-title":"StatPearls","author":"Danishyar","year":"2024"},{"key":"2026102312062575200_ref2","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1056\/NEJMcp2400531","article-title":"Otitis Media in Young Children","volume":"392","author":"Shaikh","year":"2025","journal-title":"N Engl J Med"},{"key":"2026102312062575200_ref3","year":"2023"},{"key":"2026102312062575200_ref4","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.vaccine.2013.12.003","article-title":"Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era","volume":"32","author":"Zuccotti","year":"2014","journal-title":"Vaccine"},{"key":"2026102312062575200_ref5","year":"2023"},{"key":"2026102312062575200_ref6","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1186\/s12913-024-11898-w","article-title":"Burden of invasive pneumococcal disease, non-invasive all-cause pneumonia, and acute otitis media in hospitalized US children: a retrospective multi-center study from 2015 to 2020","volume":"24","author":"Mohanty","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"2026102312062575200_ref7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s00431-004-1447-4","article-title":"Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive infections and acute otitis media in children","volume":"163","author":"Zissis","year":"2004","journal-title":"Eur J Pediatr"},{"key":"2026102312062575200_ref8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s41479-018-0055-4","article-title":"Streptococcus pneumoniae outbreaks and implications for transmission and control: a systematic review","volume":"10","author":"Zivich","year":"2018","journal-title":"Pneumonia Nathan Qld"},{"key":"2026102312062575200_ref9","doi-asserted-by":"publisher","first-page":"215265671990033","DOI":"10.1177\/2152656719900338","article-title":"Low baseline pneumococcal antibody Titers predict specific antibody deficiency, increased upper respiratory infections, and allergy sensitization","volume":"11","author":"Song","year":"2020","journal-title":"Allergy Rhinol"},{"key":"2026102312062575200_ref10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/00034894231182745","article-title":"Non-protective immunity after standard pneumococcal vaccination series identified as a potential contributing risk factor for refractory otolaryngologic conditions in children","volume":"133","author":"Bonaventure","year":"2024","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2026102312062575200_ref11","doi-asserted-by":"publisher","first-page":"ofae220","DOI":"10.1093\/ofid\/ofae220","article-title":"Immunogenicity of current and next-generation pneumococcal conjugate vaccines in children: current challenges and upcoming opportunities","volume":"11","author":"Feemster","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2026102312062575200_ref12","doi-asserted-by":"publisher","first-page":"C15","DOI":"10.1016\/j.vaccine.2009.06.008","article-title":"Essential criteria for evaluation of pneumococcal conjugate vaccine candidates","volume":"27","author":"Paradiso","year":"2009","journal-title":"Vaccine."},{"key":"2026102312062575200_ref13","doi-asserted-by":"publisher","first-page":"126295","DOI":"10.1016\/j.vaccine.2024.126295","article-title":"Modeling conjugate vaccine and natural induced antibody correlates of protection for pneumococcal colonization and acute otitis media infection in young children","volume":"42","author":"Pham","year":"2024","journal-title":"Vaccine."},{"key":"2026102312062575200_ref14"},{"key":"2026102312062575200_ref15","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1128\/CVI.00235-14","article-title":"Multilaboratory assessment of threshold versus fold-change algorithms for minimizing analytical variability in multiplexed pneumococcal IgG measurements","volume":"21","author":"Daly","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"2026102312062575200_ref16","doi-asserted-by":"publisher","first-page":"CD001480","DOI":"10.1002\/14651858.CD001480.pub6","article-title":"Pneumococcal conjugate vaccines for preventing acute otitis media in children","volume":"2020","author":"S\u00e9vaux","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2026102312062575200_ref17","doi-asserted-by":"publisher","first-page":"1544359","DOI":"10.3389\/fpubh.2025.1544359","article-title":"Serotype distribution of invasive and non-invasive pneumococcal disease in children \u22645\u00a0years of age following the introduction of 10- and 13-valent pneumococcal conjugate vaccines in infant national immunization programs: a systematic literature review","volume":"13","author":"Izurieta","year":"2025","journal-title":"Front Public Health"},{"key":"2026102312062575200_ref18","doi-asserted-by":"publisher","first-page":"126692","DOI":"10.1016\/j.vaccine.2024.126692","article-title":"A comprehensive analysis of serotype-specific invasive capacity, clinical presentations, and mortality trends of invasive pneumococcal disease","volume":"47","author":"Yildirim","year":"2025","journal-title":"Vaccine"},{"key":"2026102312062575200_ref19","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1097\/01.inf.0000220231.79968.f6","article-title":"Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis","volume":"25","author":"Shouval","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"2026102312062575200_ref20","doi-asserted-by":"publisher","first-page":"e54333","DOI":"10.1371\/journal.pone.0054333","article-title":"Dynamics of Streptococcus pneumoniae serotypes causing acute otitis media isolated from children with spontaneous middle-ear drainage over a 12-year period (1999-2010) in a region of northern Spain","volume":"8","author":"Alonso","year":"2013","journal-title":"PloS One"},{"key":"2026102312062575200_ref21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"2026102312062575200_ref22","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/INF.0000000000004334","article-title":"A Phase three study of the Safety and immunogenicity of a four-dose series of 20-Valent pneumococcal conjugate vaccine in healthy infants","volume":"43","author":"Senders","year":"2024","journal-title":"Pediatr Infect Dis J"},{"key":"2026102312062575200_ref23","author":"Pfizer","year":"2023"},{"key":"2026102312062575200_ref24","doi-asserted-by":"publisher","first-page":"CD001480","DOI":"10.1002\/14651858.CD001480.pub4","article-title":"Pneumococcal conjugate vaccines for preventing otitis media","volume":"4","author":"Fortanier","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2026102312062575200_ref25","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.vaccine.2019.01.064","article-title":"Does pneumococcal conjugate vaccination affect onset and risk of first acute otitis media and recurrences?","volume":"37","author":"Fortanier","year":"2019","journal-title":"A primary care-based cohort study Vaccine"},{"key":"2026102312062575200_ref26","doi-asserted-by":"publisher","first-page":"e1103","DOI":"10.1542\/peds.2008-3422","article-title":"Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis","volume":"123","author":"Pavia","year":"2009","journal-title":"Pediatrics."},{"key":"2026102312062575200_ref27","first-page":"283","article-title":"Evaluation of postimmunization pneumococcal titers in children with recurrent infections and normal levels of immunoglobulin","volume":"70","author":"Zora","year":"1993","journal-title":"Ann Allergy"},{"key":"2026102312062575200_ref28","doi-asserted-by":"publisher","first-page":"e0305892","DOI":"10.1371\/journal.pone.0305892","article-title":"A dynamic transmission model for assessing the impact of pneumococcal vaccination in the United States","volume":"20","author":"Malik","year":"2025","journal-title":"PloS One"},{"key":"2026102312062575200_ref29","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/14760584.2024.2416229","article-title":"Indirect protection in adults \u226518 years of age from pediatric pneumococcal vaccination: a review","volume":"23","author":"Flem","year":"2024","journal-title":"Expert Rev Vaccines"},{"key":"2026102312062575200_ref30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.vaccine.2013.05.005","article-title":"Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects","volume":"32","author":"Davis","year":"2013","journal-title":"Vaccine"},{"key":"2026102312062575200_ref31","doi-asserted-by":"publisher","first-page":"e2023065483","DOI":"10.1542\/peds.2023-065483","article-title":"Strategies for improving vaccine communication and uptake","volume":"153","author":"O\u2019Leary","year":"2024","journal-title":"Pediatrics"}],"container-title":["Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpubhealth\/advance-article-pdf\/doi\/10.1093\/pubmed\/fdag081\/72444011\/fdag081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpubhealth\/advance-article-pdf\/doi\/10.1093\/pubmed\/fdag081\/72444011\/fdag081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:06:36Z","timestamp":1792771596000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpubhealth\/advance-article\/doi\/10.1093\/pubmed\/fdag081\/8993990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":31,"URL":"https:\/\/doi.org\/10.1093\/pubmed\/fdag081","relation":{},"ISSN":["1741-3842","1741-3850"],"issn-type":[{"value":"1741-3842","type":"print"},{"value":"1741-3850","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"article-number":"fdag081"}}